George T Grossberg Selected Research

Memantine (Namenda)

10/2018	An evaluation of memantine ER + donepezil for the treatment of Alzheimer's disease.
7/2018	Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
1/2016	A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.
7/2015	The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
1/2015	Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor.
6/2013	The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.
10/2011	Use of memantine for the treatment of dementia.
7/2010	Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.
1/2009	Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
1/2009	Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George T Grossberg Research Topics

Disease

48	Alzheimer Disease (Alzheimer's Disease) 08/2022 - 01/2003
21	Dementia (Dementias) 01/2021 - 01/2002
7	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2002
5	Cognitive Dysfunction 01/2022 - 05/2014
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 01/2002
3	Disease Progression 01/2019 - 01/2013
3	Vomiting 01/2016 - 04/2003
2	Hallucinations (Hallucination) 01/2021 - 01/2021
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 01/2019
2	Weight Gain 10/2020 - 02/2009
2	Headache (Headaches) 01/2020 - 06/2013
2	Neuroinflammatory Diseases 01/2020 - 01/2017
2	Lewy Body Disease (Lewy Body Dementia) 01/2019 - 01/2002
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2017 - 02/2006
2	Amyloid Plaque 11/2017 - 10/2005
2	Syncope (Fainting) 01/2016 - 07/2015
2	Nausea 01/2016 - 04/2003
2	Stroke (Strokes) 02/2010 - 06/2008
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Confusion (Bewilderment) 01/2021
1	Schizophrenia (Dementia Praecox) 10/2020
1	Sleepiness 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Deglutition Disorders (Dysphagia) 10/2018
1	Chronic Renal Insufficiency 11/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2017
1	Inflammation (Inflammations) 11/2017
1	Weight Loss (Weight Reduction) 01/2016
1	Bradycardia 07/2015
1	Dysthymic Disorder 02/2014
1	Diarrhea 06/2013
1	Phantom Limb (Phantom Limbs) 01/2011
1	Pain (Aches) 01/2011
1	Myocardial Infarction 02/2010
1	Diabetes Mellitus 02/2009
1	Neurobehavioral Manifestations 10/2005
1	Vision Disorders (Hemeralopia) 07/2005
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2002

Drug/Important Bio-Agent (IBA)

21	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2020 - 01/2003
20	Rivastigmine (Exelon)FDA LinkGeneric 01/2021 - 01/2002
15	Memantine (Namenda)FDA Link 10/2018 - 01/2004
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 11/2005
6	Cholinergic Agents (Cholinergics)IBA 01/2019 - 04/2003
6	Donepezil (Aricept)FDA LinkGeneric 10/2018 - 04/2003
5	Antipsychotic Agents (Antipsychotics)IBA 10/2020 - 06/2008
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 10/2005
4	Galantamine (Galanthamine)FDA LinkGeneric 07/2015 - 04/2003
3	Pharmaceutical PreparationsIBA 04/2020 - 01/2013
3	Cholinesterases (Cholinesterase)IBA 07/2018 - 01/2003
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2015
2	tau Proteins (tau Protein)IBA 01/2021 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2015
2	Capsules (Microcapsules)IBA 01/2016 - 12/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	iloperidone FDA Link 10/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2020
1	hydromethylthionineIBA 04/2020
1	brexpiprazoleIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Apolipoprotein E4IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	LithiumIBA 11/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Investigational DrugsIBA 08/2016
1	tartaric acid (tartrate)FDA Link 01/2016
1	7- chloro- N- quinuclidin- 3- yl- benzo(b)thiophene- 2- carboxamideIBA 01/2015
1	A-factor (Streptomyces)IBA 01/2015
1	Testosterone (Sustanon)FDA Link 02/2014
1	Tacrine (Cognex)FDA Link 01/2009
1	Haloperidol (Haldol)FDA LinkGeneric 06/2008
1	Glutamic Acid (Glutamate)FDA Link 07/2006
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 02/2006
1	CarbamatesIBA 09/2005
1	AcetylcholinesteraseIBA 04/2003
1	ButyrylcholinesteraseIBA 04/2003
1	Buspirone (Buspar)FDA LinkGeneric 01/2003
1	BenzodiazepinesIBA 01/2003

Therapy/Procedure

21	Therapeutics 01/2021 - 11/2005
13	Activities of Daily Living (ADL) 04/2015 - 01/2004
5	Home Nursing (Nursing, Home) 01/2021 - 01/2004
4	Drug Therapy (Chemotherapy) 08/2022 - 11/2017
3	Transdermal Patch 12/2011 - 12/2010
2	Long-Term Care 02/2009 - 07/2005
1	Ketogenic Diet 01/2022
1	Mediterranean Diet 01/2022
1	Off-Label Use 01/2021
1	Institutionalization (Institutionalized Persons) 01/2019
1	Polypharmacy 01/2019
1	Surgical Amputation (Amputations) 01/2011
1	Mirror Movement Therapy 01/2011
1	Secondary Prevention 02/2010
1	Patient Care 01/2008